Astra Space, Inc. - Class A Common Stock ASTR 深 沪
已收盘 07-18 16:00:00 美东时间
0.539
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 0.539
- 总市值 1223.88万
- 52周最高 6.363
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 0.4922
- 委 比 0.00%
- 总股本 2270.65万
- 历史最高 337.05
- 量 比 0
- 振 幅 0.00%
- 历史最低 0.4922
- 每 手 1
- 风险率 0.56%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Astra Exploration Secures C$5.0M for Latin American Projects
Astra Exploration Inc ( ($TSE:ASTR) ) has provided an update. Astra Exploration...
09-30 06:07
Reported Sunday, Veracyte Announces BALANCE Trial Results Showing PAM50 Biomarker Predicts Apalutamide Benefit With Salvage Radiation In Prostate Cancer
Findings from the first prospective validation trial for biomarker presented at ASTRO 2025
09-29 14:34
RaySearch Brings Next-Level Innovation to ASTRO 2025
STOCKHOLM, Sept. 26, 2025 /PRNewswire/ -- RaySearch Laboratories AB (publ) is proud to announce its participation at ASTRO in San Francisco, California, September 28-30, where state of the a...
09-26 15:38
Johnson & Johnson Receives FDA Approval For Subcutaneous Induction Regimen Of TREMFYA; TREMFYA Offers The Flexibility Of Self-Administration From The Start Of Treatment, Building On The Prior Approval Of Subcutaneous Induction In Crohn's Disease;
HORSHAM, Pa., Sept. 19, 2025 /PRNewswire/ -- Johnson & Johnson (NYSE:JNJ) today announced that the U.S. Food and Drug Administration (FDA) has approved a subcutaneous (SC) induction regimen of TREMFYA®
09-20 05:32
Astra Exploration Mobilizes for Phase II Drilling at La Manchuria
Astra Exploration Inc ( ($TSE:ASTR) ) has shared an announcement. Astra Explora...
09-12 02:02
Amgen Rocatinlimab's Data Shows Potential As Long-Term Therapy For Atopic Dermatitis
Amgen and Kyowa Kirin report positive interim results for rocatinlimab, showing long-term safety and sustained efficacy in moderate to severe atopic dermatitis patients.
09-10 03:06
Cans gone wild: High Noon recall after vodka sneaks into Celsius cans
High Noon is recalling certain 12-packs of its vodka seltzers due to a mislabeling issue involving Celsius (NASDAQ:CELH) energy drinks. The U.S. Food and Drug Administration issued a recall order for...
08-01 00:57
正泰新能常务副总裁黄海燕：出海征途从走出去到造出去 | 2025出海大会
7月25日，由浙江省商务厅、金砖国家特殊经济区中国合作中心秘书处、杭州市商务局、钱塘区商务局指导，36氪、钱塘建设集团联合主办的2025「以“匠心”至“世界”...
07-28 18:24
全球研发 | 从全球首个到本土可及，H药 汉斯状日本小细胞肺癌桥接试验完成首例患...
2025年6月25日，复宏汉霖（2696.HK）宣布，公司自主研发的H药 汉斯状（斯鲁利单抗，欧洲商品名：Hetronifly）在日本开展的桥接临床试验（NC...
06-26 19:02
汉斯状在英国和印度获批，用于广泛期小细胞肺癌一线治疗
内容来源：复宏汉霖 ● 汉斯状是全球首个获批一线治疗ES-SCLC的抗PD-1单抗，迄今惠及逾110,000位患者 ● 汉斯状目前已在近40个国家和地区获批上市...
06-24 18:25
